Effectiveness of immunotherapy in myasthenia gravis: epidemiological evidence from Sri Lanka (original) (raw)

Etiology of myasthenia gravis: Innate immunity signature in pathological thymus

Paola Cavalcante

Autoimmunity Reviews, 2013

View PDFchevron_right

Recommendations for myasthenia gravis clinical trials

Gary Cutter

Muscle & Nerve, 2013

View PDFchevron_right

Clinical Profile of Patients with Myasthenia Gravis Admitted In a Tertiary Care Centre in India

IOSR Journals

View PDFchevron_right

Mild Clinical Expression of Myasthenia Gravis Associated with Autoimmune Thyroid Diseases 1

Bruno Rossi

The Journal of Clinical Endocrinology & Metabolism, 1997

View PDFchevron_right

Diagnosis and Management of Autoimmune Myasthenia Gravis

Corrado Angelini

2011

View PDFchevron_right

Resolution of Autoimmune Oophoritis after Thymectomy in a Myasthenia Gravis Patient

Erdal Eren

J Clin Res Pediatr En …, 2011

View PDFchevron_right

EFFECTS OF SOME IMMUNOSUPPRESSIVE PROCEDURES ON MYASTHENIA GRAVIS*

Lennart Hammarström

Annals of the New York Academy of Sciences, 1976

View PDFchevron_right

Myasthenia gravis: Immunological mechanisms and immunotherapy

Robert Lisak

Annals of Neurology, 1995

View PDFchevron_right

Evidence of underdiagnosis of myasthenia gravis in older people

lucky clover

Journal of Neurology, Neurosurgery & Psychiatry, 2003

View PDFchevron_right

Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis

Janice Massey

Journal of Autoimmunity, 2014

View PDFchevron_right

Serological and Clinical Features of Patients with Myasthenia Gravis in North Indian Population

Sumit Singh

International Journal of Neuroscience, 2010

View PDFchevron_right

Clinical and immunological differences between early and late-onset myasthenia gravis in Japan

Norihiro Suzuki

Journal of Neuroimmunology, 2011

View PDFchevron_right

Prospects for specific immunotherapy in myasthenia gravis

Renato Mantegazza

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1990

View PDFchevron_right

Immunosuppressive Treatments: Their Efficacy on Myasthenia Gravis Patients' Outcome and on the Natural Course of the Disease

Renato Mantegazza

Annals of the New York Academy of Sciences, 1993

View PDFchevron_right

Myasthenia gravis : Presentation and outcome in 104 patients managed in a single institution

Nura Alkali

Annals of Saudi Medicine, 2008

View PDFchevron_right

Complicating autoimmune diseases in myasthenia gravis: a review

Vitalie Lisnic

Autoimmunity, 2015

View PDFchevron_right

Perioperative management of the patient with Myasthenia gravis

Orlando Carrillo Torres

Revista M�dica del Hospital General de M�xico, 2019

View PDFchevron_right

Myasthenia Gravis: A Review of Available Treatment Approaches

Jone Owe

Autoimmune Diseases, 2011

View PDFchevron_right

Myasthenia Gravis and Associated Diseases

Rozalinda Isjanovska

Open Access Macedonian Journal of Medical Sciences, 2018

View PDFchevron_right

Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals

Henry Kaminski

Neurology, 2009

View PDFchevron_right

Myasthenia gravis: a clinical-immunological update

Abeer Rashid

View PDFchevron_right

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

Mahtab Ramezani

The Lancet Neurology, 2020

View PDFchevron_right

Myasthenia Gravis and Autoimunne Thyroid Disease Association

Hülya Tireli

Haydarpasa Numune Training and Research Hospital Medical Journal, 2019

View PDFchevron_right

Epidemiological Study of Myasthenia Gravis in Patients Referring to Farshchian Hospital in Hamadan

Azadeh Naderi

International Electronic Journal of Medicine, 2020

View PDFchevron_right

Safety of long-term combined immunosuppressive treatment in myasthenia gravis – analysis of adverse effects of 163 patients

G. Lovas, Samuel Komoly

European Journal of Neurology, 2006

View PDFchevron_right